BioLargo, Inc. (BLGO) shareholders
Close on Oct 19, 2026Market cap $23.27MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BLGO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| First American Trust, Fsb | 117,838 | 0.04% | $13.38K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2026 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q4 2024 | 2 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
| Q3 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2023 | 2 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
| Q3 2023 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Dennis P. Calvert | President, Director | 15,518,689 | 4.72% | Oct 2, 2026 |
| Kenneth Reay Code | Chief Science Officer, Director | 47,113,592 | 14.33% | Oct 2, 2026 |
| Charles K. Dargan | Chief Financial Officer | 190,244 | 0.06% | Feb 3, 2026 |
| Dennis E. Marshall | Director | 414,737 | 0.13% | Oct 2, 2026 |
| Linda Park | Director | 190,362 | 0.06% | Oct 2, 2026 |
| Jack B. Strommen | Director | 9,194,123 | 2.80% | Oct 2, 2026 |
| Christina Elaine Bray | Director | – | – | Oct 2, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Kenneth Reay Code Chief Science Officer, Director | Sep 30, 2026 | Gift | −2,000,000 | – | – | 24,974,580 |
| Kenneth Reay Code Chief Science Officer, Director | Sep 30, 2026 | Award | +566,261 | $0.08 | $45.30K | 26,974,580 |
| Dennis P. Calvert President, Director | Sep 30, 2026 | Gift | +2,000,000 | – | – | 13,989,994 |
| Dennis P. Calvert President, Director | Sep 30, 2026 | Award | +931,886 | $0.08 | $74.55K | 11,989,994 |
| Kenneth Reay Code Chief Science Officer, Director | Jul 7, 2026 | Award | +532,567 | $0.11 | $58.58K | 26,408,319 |
| Dennis P. Calvert President, Director | Jul 1, 2026 | Award | +219,914 | $0.11 | $24.19K | 11,058,108 |
| Dennis P. Calvert President, Director | Jun 30, 2026 | Award | +699,569 | $0.11 | $76.95K | 10,838,194 |
| Kenneth Reay Code Chief Science Officer, Director | Mar 31, 2026 | Award | +69,444 | $0.16 | $11.11K | 25,875,752 |
| Kenneth Reay Code Chief Science Officer, Director | Dec 31, 2025 | Award | +54,803 | $0.18 | $9.86K | 25,806,308 |
| Dennis P. Calvert President, Director | Dec 31, 2025 | Award | +130,222 | $0.18 | $23.44K | 10,523,625 |
| Dennis P. Calvert President, Director | Nov 14, 2025 | Award | +310,269 | $0.16 | $49.64K | 10,393,403 |
| Kenneth Reay Code Chief Science Officer, Director | Nov 14, 2025 | Award | +313,754 | $0.16 | $50.20K | 25,751,505 |
| Kenneth Reay Code Chief Science Officer, Director | Jul 14, 2025 | Award | +181,253 | $0.20 | $36.25K | 25,131,495 |
| Dennis P. Calvert President, Director | Jul 14, 2025 | Award | +169,498 | $0.20 | $33.90K | 10,029,542 |
| Kenneth Reay Code Chief Science Officer, Director | Dec 31, 2024 | Award | +57,666 | $0.19 | $10.96K | 25,120,245 |
| Kenneth Reay Code Chief Science Officer, Director | Dec 31, 2023 | Award | +72,621 | $0.17 | $12.35K | 25,062,579 |
| Dennis P. Calvert President, Director | Dec 31, 2023 | Award | +50,557 | $0.17 | $8.59K | 9,860,044 |
| Kenneth Reay Code Chief Science Officer, Director | Sep 30, 2023 | Award | +19,010 | $0.17 | $3.23K | 24,989,958 |
| Dennis P. Calvert President, Director | Jul 24, 2023 | Award | +50,553 | $0.18 | $9.10K | 9,809,487 |
| Kenneth Reay Code Chief Science Officer, Director | Jun 30, 2023 | Award | +68,541 | $0.18 | $12.34K | 24,970,948 |
| Kenneth Reay Code Chief Science Officer, Director | Mar 31, 2023 | Award | +30,747 | $0.20 | $6.15K | 24,902,407 |
| Kenneth Reay Code Chief Science Officer, Director | Oct 3, 2022 | Award | +167,781 | $0.27 | $45.30K | 24,871,660 |
| Dennis P. Calvert President, Director | Oct 3, 2022 | Award | +100,549 | $0.27 | $27.15K | 9,758,934 |
| Dennis P. Calvert President, Director | Jul 7, 2022 | Award | +156,111 | $0.18 | $28.10K | 9,658,385 |
| Kenneth Reay Code Chief Science Officer, Director | Jun 30, 2022 | Award | +107,784 | $0.18 | $19.40K | 24,703,879 |
| Kenneth Reay Code Chief Science Officer, Director | Dec 31, 2021 | Award | +15,000 | $0.21 | $3.15K | 24,596,095 |
| Dennis P. Calvert President, Director | Dec 30, 2021 | Gift | −156,000 | – | – | 9,502,274 |
| Kenneth Reay Code Chief Science Officer, Director, 10% owner | Oct 5, 2021 | Award | +61,842 | $0.19 | $11.75K | 24,581,095 |
| Jack B. Strommen Director | Apr 20, 2021 | Conversion | +563,035 | $0.24 | $135.13K | 4,878,579 |
| Dennis P. Calvert President, Director | Apr 1, 2021 | Award | +61,758 | $0.23 | $14.20K | 9,658,274 |
| Kenneth Reay Code Chief Science Officer, Director, 10% owner | Apr 1, 2021 | Award | +75,606 | $0.23 | $17.39K | 24,519,253 |
| Kenneth Reay Code Chief Science Officer, Director, 10% owner | Dec 31, 2020 | Award | +335,840 | $0.12 | $40.30K | 24,443,647 |
| Dennis P. Calvert President, Director | Dec 31, 2020 | Award | +316,260 | $0.12 | $37.95K | 9,596,516 |
| Dennis P. Calvert President, Director | Dec 31, 2020 | Gift | −225,000 | – | – | 9,280,256 |
| Dennis P. Calvert President, Director | Oct 6, 2020 | Award | +164,331 | $0.15 | $24.65K | 9,505,256 |
| Kenneth Reay Code Chief Science Officer, Director, 10% owner | Sep 30, 2020 | Award | +185,339 | $0.15 | $27.80K | 24,107,807 |
| Dennis P. Calvert President, Director | Sep 30, 2020 | Award | +164,331 | $0.15 | $24.65K | 9,505,256 |
| Kenneth Reay Code Chief Science Officer, Director, 10% owner | Jun 30, 2020 | Award | +166,474 | $0.16 | $26.64K | 23,922,468 |
| Dennis P. Calvert President, Director | Jun 30, 2020 | Award | +200,929 | $0.16 | $32.15K | 9,340,925 |
| Dennis P. Calvert President, Director | Mar 31, 2020 | Award | +281,762 | $0.17 | $47.90K | 9,139,996 |
| Kenneth Reay Code Chief Science Officer, Director, 10% owner | Mar 31, 2020 | Award | +366,993 | $0.17 | $62.39K | 23,755,994 |
| Dennis P. Calvert President, Director | Mar 9, 2020 | Gift | −25,000 | – | – | 8,858,234 |
| Dennis P. Calvert President, Director | Dec 31, 2019 | Gift | −225,000 | – | – | 8,883,234 |
| Kenneth Reay Code Chief Science Officer, Director, 10% owner | Sep 30, 2019 | Award | +35,080 | $0.32 | $11.23K | 23,389,001 |
| Dennis P. Calvert President, Director | Jun 30, 2019 | Award | +230,219 | $0.23 | $52.95K | 9,108,234 |
| Kenneth Reay Code Chief Science Officer, Director, 10% owner | Jun 30, 2019 | Award | +235,656 | $0.23 | $54.20K | 23,353,921 |
| Joseph L. Provenzano Secretary, Director | Jun 18, 2019 | Award | +500,000 | – | – | 1,770,743 |
| Kenneth Reay Code Chief Science Officer, Director, 10% owner | Apr 29, 2019 | Award | +311,562 | $0.16 | $49.85K | 23,118,265 |
| Dennis P. Calvert President, Director | Apr 29, 2019 | Award | +268,434 | $0.16 | $42.95K | 8,878,015 |
| Kenneth Reay Code Chief Science Officer, Director, 10% owner | Dec 31, 2018 | Award | +202,845 | $0.24 | $48.68K | 22,806,703 |
| Dennis P. Calvert President, Director | Dec 31, 2018 | Award | +178,956 | $0.24 | $42.95K | 8,609,581 |
| Dennis P. Calvert President, Director | Dec 31, 2018 | Gift | −75,000 | $0.24 | $18.00K | 8,430,625 |
| Kenneth Reay Code Chief Science Officer, Director, 10% owner | Sep 30, 2018 | Award | +130,187 | $0.27 | $35.15K | 22,603,858 |
| Dennis P. Calvert President, Director | Sep 30, 2018 | Award | +119,071 | $0.27 | $32.15K | 8,505,625 |
| Kenneth Reay Code Chief Science Officer, Director, 10% owner | Jul 5, 2018 | Award | +90,553 | $0.43 | $38.94K | 22,473,671 |
| Dennis P. Calvert President, Director | Jul 5, 2018 | Award | +86,397 | $0.43 | $37.15K | 8,386,554 |
| Jack B. Strommen Director | Jun 29, 2018 | Conversion | +7,532 | $0.37 | $2.79K | 4,315,544 |
| Jack B. Strommen Director | May 18, 2018 | Conversion | +2,201,714 | $0.30 | $660.51K | 4,308,012 |
| Jack B. Strommen Director | May 2, 2018 | Conversion | +1,450,400 | $0.25 | $362.60K | 2,106,298 |
| Dennis P. Calvert President, Director | Mar 31, 2018 | Award | +150,197 | $0.26 | $39.05K | 8,300,157 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of BioLargo's stock actually held short. Settlement fails (shares not delivered on time) peaked at 599,868 shares on Oct 13, 2026 over the last 90 days.
See a number that looks wrong?